Tennessee Oncology- Nashville — Nashville, Tennessee

Public research footprint of Tennessee Oncology- Nashville, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Patients With Non-Small Cell Lung Cancer · Advanced Non-Small Cell Lung Cancer · Metastatic Castration-Resistant Prostate Cancer · Breast Cancer

Recently updated registry entries

NCT07005154 — A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer (Recruiting)
NCT07164443 — A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant… (Recruiting)
NCT06472245 — Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Tennessee Oncology- Nashville?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.